MD William E. Winter (Professor of Pathology, Immunology & Laboratory Medicine, Pediatrics, and Molecular Genetics & Microbiology, Medical Director & Section Chief, Clinical Chemistry Director)
{"title":"The use of islet autoantibody markers in the prediction of autoimmune type 1 diabetes","authors":"MD William E. Winter (Professor of Pathology, Immunology & Laboratory Medicine, Pediatrics, and Molecular Genetics & Microbiology, Medical Director & Section Chief, Clinical Chemistry Director)","doi":"10.1016/S0197-1859(00)80037-0","DOIUrl":null,"url":null,"abstract":"<div><p>The detection of iselt autoantibodies provides a powerful tool for the prediction of type 1 diabetes. Combining initial genetic screening with later autoantibody testing may be the most efficacious approach to identifying beta-cell autoimmunity. Once safe and effective interventional methods are available, widespread public health service projects should be undertaken to prevent type 1 diabetes. Table 10 summarizes the use of autoantibody markers in the prediction of type 1 diabetes.</p></div>","PeriodicalId":100270,"journal":{"name":"Clinical Immunology Newsletter","volume":"19 3","pages":"Pages 25-39"},"PeriodicalIF":0.0000,"publicationDate":"1999-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S0197-1859(00)80037-0","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Immunology Newsletter","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0197185900800370","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2
Abstract
The detection of iselt autoantibodies provides a powerful tool for the prediction of type 1 diabetes. Combining initial genetic screening with later autoantibody testing may be the most efficacious approach to identifying beta-cell autoimmunity. Once safe and effective interventional methods are available, widespread public health service projects should be undertaken to prevent type 1 diabetes. Table 10 summarizes the use of autoantibody markers in the prediction of type 1 diabetes.